News

AACR 2024: Can Ferroptosis Induction Overcome Chemoresistance in NSCLC?

AACR 2024: Indoor Aerosol Carcinogens and Nonsmoking-Related Lung Cancer

Alectinib Approved by FDA as Adjuvant Therapy for ALK-Positive NSCLC

AACR 2024: Estrogen Metabolites and Lung Cancer Among Never-Smokers

AACR 2024: Does Vaping, in Addition to Smoking, Increase the Risk for Lung Cancer?

AACR 2024: New Data Reveal Mutagenic Forces May Cause Lung Cancer in Nonsmokers

Can Deep Learning Algorithm Predict Brain Metastasis in Patients With Lung Cancer?

Researchers Develop Novel Pan-Cancer Biomarker to Assess Tumor Microenvironment

SSO 2024: Is Image-Based Obesity Linked to Metabolic Pathway Alterations in NSCLC?

DNA Methylation: Researchers in Search of a Better Way to Screen for Lung Cancer

Are Immune-Related Adverse Events Associated With Overall Survival in NSCLC?

Understanding Acquired Resistance to Immunotherapy for NSCLC: Genomic and Immunophenotypic Insights

Updated Data on Entrectinib in NTRK Fusion–Positive NSCLC

ESMO Virtual Plenary: Neoadjuvant Tislelizumab Plus Chemotherapy and Adjuvant Tislelizumab for NSCLC

Racial Disparities in NSCLC: Biologic and Social Factors in Diagnosing Hispanic Individuals

FDA Approves Bispecific Antibody Plus Chemotherapy for EGFR Exon 20 Insertion–Mutated NSCLC

Using Deep Learning–Based Framework to Classify Lung Cancer Histology and Prognosis

FDA Brief: Breakthrough Therapy Designation Granted to Two Tyrosine Kinase Inhibitors in NSCLC

CheckMate 722: Final Results With Nivolumab Plus Chemotherapy in Metastatic NSCLC

Osimertinib With Chemotherapy Granted FDA Approval for EGFR-Mutated NSCLC

Cardiac Health and Lung Cancer Treatments: A Complex Balancing Act for Oncologists

FDA Approves Tepotinib for Metastatic NSCLC Harboring MET Exon 14 Skipping Alterations

Patient Age and Sex: Indicators for Segmentectomy vs Lobectomy in Pure-Solid NSCLC?

Is Medicaid Expansion Under the ACA Linked to Better Survival After Surgery for NSCLC?

STS 2024: Risk Factors and Predictors of VTE in Patients Undergoing Lung Cancer Surgery

Survey Says Medical Oncologists Favor More Research on Combination Therapies for Advanced NSCLC

NTRK Fusions in NSCLC: Improving Detection With Novel Methodology

DICER1 Hotspot Mutations in NSCLC: Clinical Implications for Genetic Testing

Using Machine Learning and CT Radiomics to Predict Brain Metastasis in Patients With NSCLC

Evaluating the Risk of Long QT Syndrome Risk in Older Patients Treated With Osimertinib for NSCLC

Could Adjuvant Chemotherapy Improve Survival Among High-Risk Patients With Stage IB NSCLC?

Targeted Therapies for NSCLC: Pathways to Fertility and Motherhood

Is First-Line Immunotherapy Efficacy Impacted by Race or Ethnicity in Advanced NSCLC?

Concurrent Chemoradiation With Dose-Escalation Ablative Radiotherapy for Unresectable NSCLC

Study Finds Clinical Benefit of Repotrectinib in ROS1 Fusion–Positive NSCLC

Next-Generation Sequencing in NSCLC: Racial Inequities in the Community Setting